Drug resistance,
meet the AI revolution.

Drug resistance,
meet the AI revolution.

The problem.

Appropriate antibiotic treatment can mean the difference between life and death for hospital patients with serious bacterial infections. Unfortunately, doctors must act days before lab results can reveal the best treatment path.
The result? A steady stream of antibiotic overuse and the rising tide of drug resistance. Without faster diagnostics that clinicians can trust, even routine surgeries and medical treatments could soon be in jeopardy.

The problem.

Appropriate antibiotic treatment can mean the difference between life and death for hospital patients with serious bacterial infections. Unfortunately, doctors must act days before lab results can reveal the best treatment path.
The result? A steady stream of antibiotic overuse and the rising tide of drug resistance. Without faster diagnostics that clinicians can trust, routine surgeries and medical treatments could soon be in jeopardy.

More than 700,000 people die each year from drug-resistant bacterial infections—a figure that could soar to 10 million by 2050.

The solution – a new gold standard.

Pattern’s single-cell microbiology technology will deliver pathogen identification (ID) and antibiotic susceptibility test (AST) results together within hours.

The solution – a new gold standard.

Pattern’s single-cell microbiology technology will deliver pathogen identification (ID) and antibiotic susceptibility test (AST) results together within hours.

2 – 4 days

Traditional culture

The growth and isolation of millions of cells

Current lab tests take days to complete because they rely on the time-consuming growth and average response of millions of bacteria to the antibiotics being considered for treatment.

4 hours

Single-cell microbiology

Bypasses growth by isolating individual cells

Our proprietary single-cell analysis technology shortens test time by “zooming in” and measuring the live response of each pathogenic cell directly, bypassing the need for time-consuming culture steps.

The AI advantage.

Advances in AI and deep learning have enabled us to recast assay development as a software problem.

The AI advantage.

Advances in AI and deep learning have enabled us to recast assay development as a software problem.
Hypothesis-free
Deep learning will observe how living cells actually respond, all at a scale never before possible. Single-cell analysis will produce millions of measurements per run.
All resistance mechanisms
Phenotypic pattern recognition will cover every resistance mechanism: known, unknown, existing, emerging, simple, complex, genetic, or epigenetic.
6x more patients than any other rapid AST platform
Pattern's technology enables testing directly from non-sterile specimens. It enhances the attributes that have made traditional culture the gold standard for bacterial diagnosis.
Most cost effective
Faster test results help guide treatment decisions, reducing the risk of antibiotic misuse. Decreased antibiotic costs and shorter hospital stays help doctors serve more patients and lower the cost of care.

Hypothesis-free

Deep learning will recognize how living cells actually respond, all at a scale never before possible. Single-cell analysis will produce millions of measurements per run.

All resistance mechanisms

Phenotypic pattern recognition will cover every resistance mechanism: known, unknown, existing, emerging, simple, complex, genetic, or epigenetic.

Most cost effective

Faster test results help guide treatment decisions, reducing the risk of antibiotic misuse. Decreased antibiotic costs and shorter hospital stays help doctors serve more patients and lower the cost of care.

6x more patients than any other rapid AST platform

Pattern’s technology enables testing directly from non-sterile specimens. It enhances the attributes that have made traditional culture the gold standard for bacterial diagnosis.

Trusted, actionable diagnosis.

Pattern provides rapid results while maintaining the comprehensive accuracy of bacterial culture.

Phenotypic

Measuring the phenotypic bacterial response to antibiotics ensures that the clinical validity of the current gold standard is maintained for rapid testing.

Syndromic

Comprehensive pathogen coverage permits symptom-based testing. Few assumptions are required about the pathogens causing the infection.

Quantitative

Quantification at single-cell resolution enables a detailed understanding of the microbial distribution within a patient sample, which is critical for diagnosing complex infections.

Measuring the phenotypic bacterial response to antibiotics ensures that the clinical validity of the current gold standard is maintained for rapid testing.

Comprehensive pathogen coverage permits symptom-based testing. Few assumptions are required about the pathogens causing the infection.

Quantification at single-cell resolution enables a detailed understanding of the microbial distribution within a patient sample, which is critical for diagnosing complex infections.

The world can’t wait.

Our mission is simple: We will improve the world’s most important health decisions.

Trusted, actionable diagnosis.

Pattern offers the comprehensive accuracy of bacterial culture in a rapid digital format.

Phenotypic

Measuring the phenotypic bacterial response to antibiotics ensures that the clinical validity of the current gold standard is maintained for rapid testing.

Syndromic

Comprehensive pathogen coverage permits symptom-based testing. Few assumptions are required about the pathogens causing the infection.

Quantitative

Quantification at single-cell resolution enables a detailed understanding of the microbial distribution within a patient sample, which is critical for diagnosing complex infections.

The world can’t wait.

Our mission is simple:

We will improve the world’s most important health decisions.